KVKS Choudary

My first question is with regard to MUPS Block. Can you give us an idea about the current capacity utilization in the product from that line?

My second question is with regard to Granules Incorporated, GI Incorporated. We have had some controlled substances approvals and as well as ADHD. But the ramp up doesn't seem to be commensurate with the number of approvals. What is the current investment and asset turnover EBITDA in Granules?

The controlled substances are not under patent. Isn't it possible for you to launch them immediately?